Star Combo Pharma Ltd (S66) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Star Combo Pharma Ltd (S66) has a cash flow conversion efficiency ratio of 0.001x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$27.67K ≈ $19.58K USD) by net assets (AU$38.26 Million ≈ $27.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Star Combo Pharma Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Star Combo Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read S66 current and long-term liabilities for a breakdown of total debt and financial obligations.
Star Combo Pharma Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Star Combo Pharma Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Theta Edge Bhd
KLSE:9075
|
-0.100x |
|
Precio Fishbone AB (publ)
ST:PRCO-B
|
0.004x |
|
Manganese X Energy Corp
V:MN
|
-0.220x |
|
Clime Investment Management Ltd
AU:CIW
|
0.026x |
|
VONEX Ltd
AU:VN8
|
-0.010x |
|
Prajay Engineers Syndicate Limited
NSE:PRAENG
|
0.052x |
|
High-Tech Metals Ltd
AU:HTM
|
-0.072x |
|
Mexco Energy Corporation
NYSE MKT:MXC
|
0.044x |
Annual Cash Flow Conversion Efficiency for Star Combo Pharma Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Star Combo Pharma Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Star Combo Pharma Ltd (S66) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$38.26 Million ≈ $27.07 Million |
AU$11.94 Million ≈ $8.45 Million |
0.312x | +3404.96% |
| 2024-06-30 | AU$33.51 Million ≈ $23.71 Million |
AU$-316.45K ≈ $-223.91K |
-0.009x | -116.74% |
| 2023-06-30 | AU$33.26 Million ≈ $23.53 Million |
AU$1.88 Million ≈ $1.33 Million |
0.056x | +2193.37% |
| 2022-06-30 | AU$35.41 Million ≈ $25.05 Million |
AU$87.11K ≈ $61.64K |
0.002x | -73.14% |
| 2021-06-30 | AU$36.19 Million ≈ $25.61 Million |
AU$331.53K ≈ $234.58K |
0.009x | +140.03% |
| 2020-06-30 | AU$44.50 Million ≈ $31.49 Million |
AU$-1.02 Million ≈ $-720.42K |
-0.023x | +79.06% |
| 2019-06-30 | AU$20.00 Million ≈ $14.15 Million |
AU$-2.19 Million ≈ $-1.55 Million |
-0.109x | +3.35% |
| 2018-06-30 | AU$16.26 Million ≈ $11.50 Million |
AU$-1.84 Million ≈ $-1.30 Million |
-0.113x | -290.16% |
| 2017-06-30 | AU$15.68 Million ≈ $11.10 Million |
AU$932.20K ≈ $659.59K |
0.059x | -82.19% |
| 2016-06-30 | AU$3.88 Million ≈ $2.75 Million |
AU$1.30 Million ≈ $917.50K |
0.334x | -- |
About Star Combo Pharma Ltd
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more